Edwards Lifesciences Corporation
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| E1WL34.SA | MDT | 7575.T | 2291.HK | 2160.HK | AORT | |
|---|---|---|---|---|---|---|
| Market cap | 240.94B | 134.26B | 118.28B | 4.95B | 1.63B | 1.29B |
| P/E (TTM) | 47.1 | 25.8 | 13.1 | 22.1 | — | — |
| Forward P/E | — | 16.4 | 13.8 | 7.7 | 37.9 | 35.3 |
| Price/book | 1.2 | 2.7 | 1.8 | 2.1 | 0.8 | 2.9 |
| Dividend yield | — | 2.74% | 3.45% | 4.04% | — | — |
| 1-year change | +2.37% | +16.54% | +11.48% | −24.59% | −77.54% | −44.32% |
| Today | 0.00% | +6.15% | +3.95% | +2.75% | 0.00% | +11.56% |
The closest companies by business and industry (Medical Devices). Prices may be delayed up to 20 min.
Latest news
All E1WL34.SA news ›Edwards Lifesciences Advances Over 4% Following Truist Upgrade
Edwards Lifesciences gained 4.28% on Wednesday, closing at $99.26 in New York, as investor sentiment improved following a broker upgrade. The stock added $4.07 during the session after Truist Securities raised its rating on the medical…
Edwards Lifesciences Corporation (EW) Q3 2026 Earnings Call Transcript
Edwards Lifesciences Corporation (EW) Q3 2026 Earnings Call November 4, 2026 5:00 PM EST Gerianne Sarte - Investor Relations OfficerBernard Zovighian - CEO & DirectorTheodora Mistras - Corporate VP & CFODaniel Lippis - Corporate Vice…
Edwards Lifesciences (NYSE:EW) Issues Quarterly Earnings Results, Beats Expectations By $0.06 EPS
View Our Latest Stock Report on Edwards Lifesciences Edwards Lifesciences Corporation NYSE: EW is a medical technology company focused on therapies for structural heart disease and critical care. The company develops and manufactures…
Edwards Lifesciences (NYSE:EW) Sets New 12-Month High - Here's What Happened
Edwards Lifesciences Corporation (NYSE:EW - Get Free Report) reached a new 52-week high during trading on Wednesday. The company traded as high as $99.68 and last traded at $99.1210, with a volume of 415,242 shares traded. The stock had…
Edwards Lifesciences Corporation $EW Stock Position Lifted by AIA Group Ltd
Here are the key news stories impacting Edwards Lifesciences this week: Check Out Our Latest Analysis on EW Edwards Lifesciences Corporation NYSE: EW is a medical technology company focused on therapies for structural heart disease and…
Edwards Lifesciences Corporation (EW) Discusses CLASP II TR and PROGRESS Trial Results in Tricuspid and TAVR Transcript
Edwards Lifesciences Corporation (EW) Discusses CLASP II TR and PROGRESS Trial Results in Tricuspid and TAVR November 2, 2026 8:00 PM ESTCompany... Edwards Lifesciences Corporation (EW) Discusses CLASP II TR and PROGRESS Trial Results in…
FDA Approval of Edwards Lifesciences’ PASCAL Precision System Opens New Treatment Pathway for Patients With Tricuspid Valve Disease
Plus members following EW got this by push and email at 09:00:01 ET - 1.5s after publication. Quantisnow reads SEC filings, FDA decisions, analyst ratings, insider trades and press releases straight off the wire and alerts you on the…
Barclays initiated coverage on Edwards Lifesciences with a new price target
Plus members following EW got this by push and email at 08:50:06 ET - 1.8s after publication. Quantisnow reads SEC filings, FDA decisions, analyst ratings, insider trades and press releases straight off the wire and alerts you on the…
Edwards Lifesciences to Host Earnings Conference Call on November 4, 2026
Plus members following EW got this by push and email at 06:00:01 ET - 1.0s after publication. Quantisnow reads SEC filings, FDA decisions, analyst ratings, insider trades and press releases straight off the wire and alerts you on the…
Edwards Lifesciences says PASCAL beats medical therapy for tricuspid repair
Edwards Lifesciences says its PASCAL tricuspid repair trial beat medical therapy, cutting regurgitation and boosting quality of life. Read more here. - Edwards Lifesciences (EW) said that a trial testing the PASCAL system for tricuspid…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- marketscreener.com14
- marketbeat.com10
- defenseworld.net3
- quantisnow.com3
- seekingalpha.com3
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 48 articles, not a forecast.